메뉴 건너뛰기




Volumn 42, Issue 12, 2015, Pages 2383-2391

Clinical and economic burden of antineutrophil cytoplasmic antibody-associated vasculitis in the United States

Author keywords

Antineutrophil cytoplasmic antibody associated vasculitis; Granulomatosis with polyangiitis; Healthcare expenditures; Microscopic polyangiitis; Recurrence

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; RITUXIMAB;

EID: 84948845100     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.150479     Document Type: Article
Times cited : (37)

References (24)
  • 1
    • 84948792353 scopus 로고    scopus 로고
    • [Internet. Accessed September 8]
    • Langford CA. Granulomatosis with polyangiitis (Wegener's). [Internet. Accessed September 8, 2015.] Available from: www.rheumatology.org/Practice/Clinical/Patients/Diseases-And-C onditions/Granulomatosis-with-Polyangiitis-%28Wegener-s%29/
    • (2015) Granulomatosis with Polyangiitis (wegener'S)
    • Langford, C.A.1
  • 2
    • 84905502868 scopus 로고    scopus 로고
    • Key advances in the clinical approach to ANCA-associated vasculitis
    • Kallenberg CG. Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol 2014;10:484-93.
    • (2014) Nat Rev Rheumatol , vol.10 , pp. 484-493
    • Kallenberg, C.G.1
  • 3
    • 84871251698 scopus 로고    scopus 로고
    • 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
    • Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
    • (2013) Arthritis Rheum , vol.65 , pp. 1-11
    • Jennette, J.C.1    Falk, R.J.2    Bacon, P.A.3    Basu, N.4    Cid, M.C.5    Ferrario, F.6
  • 5
    • 66949130345 scopus 로고    scopus 로고
    • Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: Two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity?
    • Mahr AD. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity? APMIS 2009;117:14-47.
    • (2009) APMIS , vol.117 , pp. 14-47
    • Mahr, A.D.1
  • 6
    • 33745682189 scopus 로고    scopus 로고
    • Case control study of ANCA associated vasculitis in western Montana
    • Zeft AS, Weiss N. Case control study of ANCA associated vasculitis in western Montana. Arthritis Rheum 2005;52:S648.
    • (2005) Arthritis Rheum , vol.52 , pp. S648
    • Zeft, A.S.1    Weiss, N.2
  • 9
    • 84899697025 scopus 로고    scopus 로고
    • Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)
    • Tarzi RM, Pusey CD. Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis). Ther Clin Risk Manag 2014;2014:279-93.
    • (2014) Ther Clin Risk Manag , vol.2014 , pp. 279-293
    • Tarzi, R.M.1    Pusey, C.D.2
  • 10
    • 34547799013 scopus 로고    scopus 로고
    • Treatment of antineutrophil cytoplasmic antibody-associated vasculitis
    • Bosch X, Guilabert A, Espinosa G, Mirapeix E. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis. JAMA 2007;298:655-69.
    • (2007) JAMA , vol.298 , pp. 655-669
    • Bosch, X.1    Guilabert, A.2    Espinosa, G.3    Mirapeix, E.4
  • 12
    • 84948752176 scopus 로고    scopus 로고
    • South San Francisco, CA: Genentech Inc
    • Rituximab package insert. South San Francisco, CA: Genentech Inc.; 2014.
    • (2014) Rituximab Package Insert
  • 13
    • 0037227218 scopus 로고    scopus 로고
    • Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis
    • Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis. J Rheumatol 2003;30:80-8.
    • (2003) J Rheumatol , vol.30 , pp. 80-88
    • Koldingsnes, W.1    Nossent, J.C.2
  • 14
    • 27644437166 scopus 로고    scopus 로고
    • Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessell vasculitis
    • Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessell vasculitis. Ann Intern Med 2005;143:621-31.
    • (2005) Ann Intern Med , vol.143 , pp. 621-631
    • Hogan, S.L.1    Falk, R.J.2    Chin, H.3    Cai, J.4    Jennette, C.E.5    Jennette, J.C.6
  • 15
    • 51849091965 scopus 로고    scopus 로고
    • Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts
    • Pagnoux C, Hogan SL, Chin H, Jennette CE, Falk RJ, Guillevin L, et al. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. Arthritis Rheum 2008;58:2908-18.
    • (2008) Arthritis Rheum , vol.58 , pp. 2908-2918
    • Pagnoux, C.1    Hogan, S.L.2    Chin, H.3    Jennette, C.E.4    Falk, R.J.5    Guillevin, L.6
  • 16
    • 78650784897 scopus 로고    scopus 로고
    • Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades
    • Holle JU, Gross WL, Latza U, Nolle B, Ambrosch P, Heller M, et al. Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 2011;63:257-66.
    • (2011) Arthritis Rheum , vol.63 , pp. 257-266
    • Holle, J.U.1    Gross, W.L.2    Latza, U.3    Nolle, B.4    Ambrosch, P.5    Heller, M.6
  • 18
    • 0026639706 scopus 로고
    • Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
    • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
    • (1992) J Clin Epidemiol , vol.45 , pp. 613-619
    • Deyo, R.A.1    Cherkin, D.C.2    Ciol, M.A.3
  • 19
    • 0348111413 scopus 로고    scopus 로고
    • Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis
    • Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DG. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 2003; 49:826-37.
    • (2003) Arthritis Rheum , vol.49 , pp. 826-837
    • Koutantji, M.1    Harrold, E.2    Lane, S.E.3    Pearce, S.4    Watts, R.A.5    Scott, D.G.6
  • 22
    • 0037097578 scopus 로고    scopus 로고
    • Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis
    • Reinhold-Keller E, Herlyn K, Wagner-Bastmever R, Gutfleisch J, Peter HH, Raspe HH, et al. Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum 2002;47:320-5.
    • (2002) Arthritis Rheum , vol.47 , pp. 320-325
    • Reinhold-Keller, E.1    Herlyn, K.2    Wagner-Bastmever, R.3    Gutfleisch, J.4    Peter, H.H.5    Raspe, H.H.6
  • 23
    • 0030042974 scopus 로고    scopus 로고
    • The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources
    • Cotch M, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996;39:87-92.
    • (1996) Arthritis Rheum , vol.39 , pp. 87-92
    • Cotch, M.1    Hoffman, G.S.2    Yerg, D.E.3    Kaufman, G.I.4    Targonski, P.5    Kaslow, R.A.6
  • 24
    • 4243896778 scopus 로고
    • The prevalence, epidemiology and cost of hospitalizations for vasculitis in New York State 1986 to 1990 [abstract]
    • Cotch MF, Hoffman GS. The prevalence, epidemiology and cost of hospitalizations for vasculitis in New York State 1986 to 1990 [abstract]. Arthritis Rheum 1995;38:S225.
    • (1995) Arthritis Rheum , vol.38 , pp. S225
    • Cotch, M.F.1    Hoffman, G.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.